Ethinylestradiol/drospirenone

Ethinylestradiol/drospirenone, sold under the brand name Yasmin among others, is a combination of ethinylestradiol, an estrogen, and drospirenone, a progestin, antimineralocorticoid, and antiandrogen, which is used as a birth control pill to prevent pregnancy in women. It is also indicated for the treatment of moderate acne, premenstrual syndrome, premenstrual dysphoric disorder, and dysmenorrhea in women. The medication is taken by mouth and contains 30 μg EE and 3 mg DRSP per tablet or 20 μg EE and 3 mg DRSP per tablet. A formulation with levomefolic acid has also been marketed, with similar indications. EE/DRSP is marketed widely throughout the world.
In 2023, it was the 154th most commonly prescribed medication in the United States, with more than 3million prescriptions.